356 related articles for article (PubMed ID: 7688438)
1. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.
Catalona WJ; Smith DS; Ratliff TL; Basler JW
JAMA; 1993 Aug; 270(8):948-54. PubMed ID: 7688438
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements.
Catalona WJ; Smith DS; Ornstein DK
JAMA; 1997 May; 277(18):1452-5. PubMed ID: 9145717
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
Mettlin C; Murphy GP; Lee F; Littrup PJ; Chesley A; Babaian R; Badalament R; Kane RA; Mostofi FK
Cancer; 1993 Sep; 72(5):1701-8. PubMed ID: 7688658
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal screening for prostate cancer with prostate-specific antigen.
Smith DS; Catalona WJ; Herschman JD
JAMA; 1996 Oct 23-30; 276(16):1309-15. PubMed ID: 8861989
[TBL] [Abstract][Full Text] [Related]
5. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.
Catalona WJ; Smith DS; Ratliff TL; Dodds KM; Coplen DE; Yuan JJ; Petros JA; Andriole GL
N Engl J Med; 1991 Apr; 324(17):1156-61. PubMed ID: 1707140
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.
Catalona WJ; Smith DS; Wolfert RL; Wang TJ; Rittenhouse HG; Ratliff TL; Nadler RB
JAMA; 1995 Oct; 274(15):1214-20. PubMed ID: 7563511
[TBL] [Abstract][Full Text] [Related]
7. Delays in cancer detection using 2 and 4-year screening intervals for prostate cancer screening with initial prostate specific antigen less than 2 ng/ml.
Kundu SD; Grubb RL; Roehl KA; Antenor JA; Han M; Catalona WJ
J Urol; 2005 Apr; 173(4):1116-20. PubMed ID: 15758718
[TBL] [Abstract][Full Text] [Related]
8. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen].
Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916
[TBL] [Abstract][Full Text] [Related]
9. The nature of prostate cancer detected through prostate specific antigen based screening.
Smith DS; Catalona WJ
J Urol; 1994 Nov; 152(5 Pt 2):1732-6. PubMed ID: 7523720
[TBL] [Abstract][Full Text] [Related]
10. Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer.
Carter HB; Epstein JI; Chan DW; Fozard JL; Pearson JD
JAMA; 1997 May; 277(18):1456-60. PubMed ID: 9145718
[TBL] [Abstract][Full Text] [Related]
11. Digital rectal examination and the diagnosis of prostate cancer--a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
Gosselaar C; Roobol MJ; van den Bergh RC; Wolters T; Schröder FH
Eur Urol; 2009 Jan; 55(1):139-46. PubMed ID: 18406045
[TBL] [Abstract][Full Text] [Related]
12. [Screening of cancer of the prostate: study in a Spanish population].
Herrero Payo JA; Montes Díaz MJ; Páez Borda A; Sánchez Sánchez E; Moreno Valle JA; Berenguer Sánchez A
Arch Esp Urol; 1996; 49(6):595-606. PubMed ID: 8929102
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic accuracy of transrectal ultrasonography for screening of prostatic cancer].
Watanabe M; Saitoh M; Watanabe H
Hinyokika Kiyo; 1996 Oct; 42(10):763-6. PubMed ID: 8951472
[TBL] [Abstract][Full Text] [Related]
14. [The significance of early detection for prostate cancer in mass screening].
Kato M; Tammbo M; Yoshimatsu T; Ohta M; Kinjyo M; Noda H; Watanabe K; Miyata A; Murata A; Miura I; Yoneda T; Yoshii M; Okegawa T; Kojima M; Sayama T; Nutahara K; Higashihara E
Nihon Hinyokika Gakkai Zasshi; 2001 Jan; 92(1):23-9. PubMed ID: 11235139
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen and digital rectal examination in screening for prostate cancer: a community-based study.
Bretton PR
South Med J; 1994 Jul; 87(7):720-3. PubMed ID: 7517580
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of prostate specific antigen for early stage prostate cancer detection.
Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J; Saitoh M; Watanabe H; Ohe H
Jpn J Clin Oncol; 1994 Jun; 24(3):160-5. PubMed ID: 7516445
[TBL] [Abstract][Full Text] [Related]
17. Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/ml or less.
Ito K; Kubota Y; Yamamoto T; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
Cancer; 2001 Feb; 91(4):744-51. PubMed ID: 11241242
[TBL] [Abstract][Full Text] [Related]
18. Optimizing prostate cancer screening; prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program.
Rubio-Briones J; Casanova J; Dumont R; Rubio L; Fernandez-Serra A; Casanova-Salas I; Domínguez-Escrig J; Ramírez-Backhaus M; Collado A; Gómez-Ferrer A; Iborra I; Monrós JL; Ricós JV; Solsona E; Salas D; Martínez F; Lopez-Guerrero JA
Actas Urol Esp; 2014 May; 38(4):217-23. PubMed ID: 24169211
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen.
Labrie F; Candas B; Cusan L; Gomez JL; Diamond P; Suburu R; Lemay M
Urology; 1996 Feb; 47(2):212-7. PubMed ID: 8607237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
